Flores, Bb Boy .

HRN: 25-88-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2024
AMPICILLIN 250MG (VIAL)
09/18/2024
09/25/2024
IVTT
250mg
Q12h
PSNB
Waiting Final Action 
09/18/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/18/2024
09/25/2024
IVTT
35mg
Q24h
PSNB
Waiting Final Action 
02/04/2025
CEFUROXIME 750MG (VIAL)
02/04/2025
02/11/2025
INTRAVENOUS
300 Mg
Every 8 Hours
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: